Stryker and Smith & Nephew are the stars to watch in medtech’s 2015 merger dance

by contributor Laura Cooper

Medical devices manufacturers had an extremely active 2014, with a number of mega-mergers in the space. With a record year in the rear view mirror and integration of these deals ongoing-it shows no sign of slowing down.

According to Paul Teitelbaum, a managing director at Mesirow Financial, there are likely to be a few mega deals on the table this year — but not on par with last year’s robust M&A environment. Teitelbaum noted that he expects 2015 and 2016 to be the years of the mid-sized players linking up with each other or selling to larger strategic players.

Teitelbaum pointed to last year’s $3.3 billion merger of Wright Medical Group (WMGI) and Tornier NV (TRNX), as an example of two mid-sized companies coming together to create a relevant entity. “I wouldn’t be surprised if we saw companies in the $1 billion to $5 billion market cap range find dance partners,” he explained, noting that mega-mergers often have a trickle-down effect on smaller companies and consolidation.

Blockbuster deals such as the $43 billion combination of Minneapolis, based-Medtronic (MDT) and Dublin, Ireland’s Covidien (COV) are also likely to spur more M&A, as the two companies integrate and evaluate their product portfolio And given the  frothy activity last year, other companies are likely to spin out certain product lines as they settle on their strategic focus.

Of course, large players should continue making smaller acquisitions of their own. For example, Medtronic acquired NGC Medical SpA — a company that manages cardiovascular suites, operating rooms and intensive care centers — in while it was digesting the Covidien deal. Teitelbaum noted that more transactions of this caliber are likely to occur among large players, adding that several are already making inquiries about potential targets.

In 2015, the marquee pairing — potentially — will be that of Stryker Corp. (SYK) and Smith & Nephew plc (SNN) The two medical devices companies have been flagged as a possible combination by industry watchers for some time. In May of last year, Kalamazoo, Mich.-based Stryker said it was not planning to make a takeover bid for the  U.K.-based Smith & Nephew at that time. However, numerous analysts and industry bankers have noted that this year may the right time for a megadeal from the two medical device players.

Read more: Stryker and Smith & Nephew are the stars to watch in medtech’s 2015 merger dance – The Deal Pipeline (SAMPLE CONTENT: NEED AN ID?)


Print Friendly, PDF & Email

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button